SK285434B6 - Farmaceutické kompozície na zosvetlenie alebo zníženie pigmentácie kože, inhibíciu tyrosinázy aleboliečenie zápalového ochorenia alebo lupín u človeka a použitie 4-(2,4-dihydroxyfenyl)cyklohexanolu na výrobu liečiv - Google Patents

Farmaceutické kompozície na zosvetlenie alebo zníženie pigmentácie kože, inhibíciu tyrosinázy aleboliečenie zápalového ochorenia alebo lupín u človeka a použitie 4-(2,4-dihydroxyfenyl)cyklohexanolu na výrobu liečiv Download PDF

Info

Publication number
SK285434B6
SK285434B6 SK1322-2001A SK13222001A SK285434B6 SK 285434 B6 SK285434 B6 SK 285434B6 SK 13222001 A SK13222001 A SK 13222001A SK 285434 B6 SK285434 B6 SK 285434B6
Authority
SK
Slovakia
Prior art keywords
pharmaceutically acceptable
dihydroxyphenyl
cyclohexanol
skin
formula
Prior art date
Application number
SK1322-2001A
Other languages
English (en)
Slovak (sk)
Other versions
SK13222001A3 (sk
Inventor
Eric William Collington
Original Assignee
Pfizer Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc. filed Critical Pfizer Inc.
Publication of SK13222001A3 publication Critical patent/SK13222001A3/sk
Publication of SK285434B6 publication Critical patent/SK285434B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0212—Face masks
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/03—Liquid compositions with two or more distinct layers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SK1322-2001A 1999-03-22 2000-03-14 Farmaceutické kompozície na zosvetlenie alebo zníženie pigmentácie kože, inhibíciu tyrosinázy aleboliečenie zápalového ochorenia alebo lupín u človeka a použitie 4-(2,4-dihydroxyfenyl)cyklohexanolu na výrobu liečiv SK285434B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12555399P 1999-03-22 1999-03-22
PCT/IB2000/000278 WO2000056279A1 (en) 1999-03-22 2000-03-14 Resorcinol composition

Publications (2)

Publication Number Publication Date
SK13222001A3 SK13222001A3 (sk) 2002-08-06
SK285434B6 true SK285434B6 (sk) 2007-01-04

Family

ID=22420269

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1322-2001A SK285434B6 (sk) 1999-03-22 2000-03-14 Farmaceutické kompozície na zosvetlenie alebo zníženie pigmentácie kože, inhibíciu tyrosinázy aleboliečenie zápalového ochorenia alebo lupín u človeka a použitie 4-(2,4-dihydroxyfenyl)cyklohexanolu na výrobu liečiv

Country Status (45)

Country Link
EP (1) EP1165031B1 (pt)
JP (1) JP2002539234A (pt)
KR (1) KR100468250B1 (pt)
CN (1) CN1213726C (pt)
AP (1) AP1413A (pt)
AR (1) AR018475A1 (pt)
AT (1) ATE297187T1 (pt)
AU (1) AU765209B2 (pt)
BG (1) BG65146B1 (pt)
BR (1) BR0009194A (pt)
CA (1) CA2366623C (pt)
CO (1) CO5160291A1 (pt)
CR (1) CR6452A (pt)
CZ (1) CZ298939B6 (pt)
DE (1) DE60020682T2 (pt)
DZ (1) DZ3022A1 (pt)
EA (1) EA003866B1 (pt)
EE (1) EE200100489A (pt)
ES (1) ES2241580T3 (pt)
GE (1) GEP20043231B (pt)
GT (1) GT200000030A (pt)
HK (1) HK1044478B (pt)
HN (1) HN2000000033A (pt)
HR (1) HRP20010696A2 (pt)
HU (1) HUP0200684A3 (pt)
ID (1) ID30272A (pt)
IL (1) IL144848A0 (pt)
IS (1) IS6052A (pt)
MA (1) MA26726A1 (pt)
MY (1) MY133193A (pt)
NO (1) NO20014586L (pt)
NZ (1) NZ513453A (pt)
OA (1) OA11840A (pt)
PA (1) PA8492001A1 (pt)
PE (1) PE20001567A1 (pt)
PL (1) PL350905A1 (pt)
PT (1) PT1165031E (pt)
SK (1) SK285434B6 (pt)
TN (1) TNSN00055A1 (pt)
TR (1) TR200102741T2 (pt)
TW (1) TWI224011B (pt)
UY (1) UY26072A1 (pt)
WO (1) WO2000056279A1 (pt)
YU (1) YU67101A (pt)
ZA (1) ZA200106681B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2816843B1 (fr) * 2000-11-23 2006-10-27 Actichem Inhibiteurs de l'enzyme 5 alpha-reductase
US20040109832A1 (en) * 2002-12-09 2004-06-10 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Di-substituted resorcinols as skin lightening agents
DE10324566A1 (de) 2003-05-30 2004-12-16 Symrise Gmbh & Co. Kg Verwendung von Diphenylmethan-Derivaten als Tyrosinase-Inhibitoren
FR2894582B1 (fr) 2005-12-12 2008-02-22 Fabre Pierre Dermo Cosmetique Sirna anti myosine va et depigmentation de la peau
FR2939136B1 (fr) * 2008-12-02 2010-12-03 Galderma Res & Dev Nouveaux composes 4-(heterocycloalkyl)-benzene-1,3-diol comme inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique
FR2939135B1 (fr) * 2008-12-02 2010-12-03 Galderma Res & Dev Nouveaux composes 4-(azacycloalkyl)-benzene-1,3-diol comme inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique
CA2976142A1 (en) * 2015-02-16 2016-08-25 Gilles Henri LASSERRE Composition for prevention or treatment of cutaneous disorder
MX2018000538A (es) 2015-07-14 2018-05-22 Unilever Nv Composicion antimicrobiana.
IT201700104536A1 (it) 2017-09-19 2019-03-19 Cmed Aesthetics Srl Prodotti topici con sistema bifasico

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4526179A (en) * 1983-01-28 1985-07-02 Leonard Salesky Digital apical foramen locating apparatus
JPH0651619B2 (ja) * 1988-05-09 1994-07-06 株式会社クラレ 美白剤
JP2875374B2 (ja) * 1990-10-31 1999-03-31 ポーラ化成工業株式会社 ニキビ用化粧料
JPH054905A (ja) * 1990-10-31 1993-01-14 Pola Chem Ind Inc 化粧料
FR2679133B1 (fr) * 1991-07-17 1993-10-15 Oreal Utilisation de derives d'acides (2,5-dihydroxyphenyl)carboxyliques, leurs homologues et leurs sels dans la preparation d'une composition cosmetique ou dermatologique a action depigmentante.
JP2790986B2 (ja) * 1995-02-27 1998-08-27 住友建設株式会社 橋脚の構築方法及び施工方法
BR9803596A (pt) * 1997-09-23 2000-04-25 Pfizer Prod Inc Derivados do resorcinol.

Also Published As

Publication number Publication date
ID30272A (id) 2001-11-15
EA003866B1 (ru) 2003-10-30
ES2241580T3 (es) 2005-11-01
IS6052A (is) 2001-08-17
DE60020682T2 (de) 2006-04-06
AU2823000A (en) 2000-10-09
EP1165031B1 (en) 2005-06-08
DE60020682D1 (de) 2005-07-14
GT200000030A (es) 2001-09-08
TNSN00055A1 (fr) 2005-11-10
IL144848A0 (en) 2002-06-30
AP2001002273A0 (en) 2001-09-30
EE200100489A (et) 2002-12-16
EA200100853A1 (ru) 2002-02-28
MY133193A (en) 2007-10-31
JP2002539234A (ja) 2002-11-19
CZ298939B6 (cs) 2008-03-19
CA2366623C (en) 2006-06-13
CO5160291A1 (es) 2002-05-30
TR200102741T2 (tr) 2002-01-21
OA11840A (en) 2005-08-22
CA2366623A1 (en) 2000-09-28
UY26072A1 (es) 2000-10-31
HUP0200684A2 (en) 2002-08-28
HK1044478B (zh) 2005-12-09
BG106016A (en) 2002-05-31
HK1044478A1 (en) 2002-10-25
NO20014586D0 (no) 2001-09-21
CN1344152A (zh) 2002-04-10
AU765209B2 (en) 2003-09-11
GEP20043231B (en) 2004-05-25
BG65146B1 (bg) 2007-04-30
AP1413A (en) 2005-03-18
PE20001567A1 (es) 2001-01-13
HRP20010696A2 (en) 2002-08-31
AR018475A1 (es) 2001-11-14
MA26726A1 (fr) 2004-12-20
WO2000056279A1 (en) 2000-09-28
HUP0200684A3 (en) 2009-11-30
KR100468250B1 (ko) 2005-01-27
DZ3022A1 (fr) 2004-03-27
CN1213726C (zh) 2005-08-10
PL350905A1 (en) 2003-02-10
ZA200106681B (en) 2002-08-14
ATE297187T1 (de) 2005-06-15
CZ20013339A3 (cs) 2002-07-17
NO20014586L (no) 2001-11-21
SK13222001A3 (sk) 2002-08-06
PA8492001A1 (es) 2002-02-21
YU67101A (sh) 2004-12-31
KR20010114233A (ko) 2001-12-31
TWI224011B (en) 2004-11-21
HN2000000033A (es) 2001-02-02
EP1165031A1 (en) 2002-01-02
BR0009194A (pt) 2001-12-18
PT1165031E (pt) 2005-09-30
NZ513453A (en) 2003-04-29
CR6452A (es) 2004-03-24

Similar Documents

Publication Publication Date Title
US6132740A (en) Resorcinol derivatives
US6933319B2 (en) Resorcinol derivatives
US6541473B2 (en) Resorcinol derivatives
US6878381B2 (en) Resorcinol composition
SK285434B6 (sk) Farmaceutické kompozície na zosvetlenie alebo zníženie pigmentácie kože, inhibíciu tyrosinázy aleboliečenie zápalového ochorenia alebo lupín u človeka a použitie 4-(2,4-dihydroxyfenyl)cyklohexanolu na výrobu liečiv
MXPA01009546A (en) Resorcinol composition
MXPA98007778A (en) Derivatives of resorci